| 11. |
- Casoni, E., et al.
(författare)
-
Alya : Computational Solid Mechanics for Supercomputers
- 2015
-
Ingår i: Archives of Computational Methods in Engineering. - : Springer Science and Business Media LLC. - 1134-3060 .- 1886-1784. ; 22:4, s. 557-576
-
Forskningsöversikt (refereegranskat)abstract
- While solid mechanics codes are now conventional tools both in industry and research, the increasingly more exigent requirements of both sectors are fuelling the need for more computational power and more advanced algorithms. For obvious reasons, commercial codes are lagging behind academic codes often dedicated either to the implementation of one new technique, or the upscaling of current conventional codes to tackle massively large scale computational problems. Only in a few cases, both approaches have been followed simultaneously. In this article, a solid mechanics simulation strategy for parallel supercomputers based on a hybrid approach is presented. Hybrid parallelization exploits the thread-level parallelism of multicore architectures, combining MPI tasks with OpenMP threads. This paper describes the proposed strategy, programmed in Alya, a parallel multi-physics code. Hybrid parallelization is specially well suited for the current trend of supercomputers, namely large clusters of multicores. The strategy is assessed through transient non-linear solid mechanics problems, both for explicit and implicit schemes, running on thousands of cores. In order to demonstrate the flexibility of the proposed strategy under advance algorithmic evolution of computational mechanics, a non-local parallel overset meshes method (Chimera-like) is implemented and the conservation of the scalability is demonstrated.
|
|
| 12. |
|
|
| 13. |
- Ribi, Karin, et al.
(författare)
-
Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
- 2019
-
Ingår i: British journal of cancer. - : Springer Science and Business Media LLC. - 1532-1827 .- 0007-0920. ; 120, s. 959-967
-
Tidskriftsartikel (refereegranskat)abstract
- In the phase III SOLE trial, the extended use of intermittent versus continuous letrozole for 5 years did not improve disease-free survival in postmenopausal women with hormone receptor-positive breast cancer. Intermittent therapy with 3-month breaks may be beneficial for patients' quality of life (QoL).In the SOLE QoL sub-study, 956 patients completed the Breast Cancer Prevention Trial (BCPT) symptom and further QoL scales up to 24 months after randomisation. Differences in change of QoL from baseline between the two administration schedules were tested at 12 and 24 months using repeated measures mixed-models. The primary outcome was change in hot flushes at 12 months.There was no difference in hot flushes at 12 months between the two schedules, but patients receiving intermittent letrozole reported significantly more improvement at 24 months. They also indicated less worsening in vaginal problems, musculoskeletal pain, sleep disturbance, physical well-being and mood at 12 months. Overall, 25-30% of patients reported a clinically relevant worsening in key symptoms and global QoL.Less symptom worsening was observed during the first year of extended treatment with the intermittent administration. For women experiencing an increased symptom burden of extended adjuvant endocrine therapy, an intermittent administration is a safe alternative.Clinical trial information: NCT00651456.
|
|
